Home News Medtech

Medtecs signs letter of intent with Enimmune to market and promote Enimmune's 'Speedy Covid-19 Ag Rapid Test'

Felicia Tan
Felicia Tan1/14/2021 05:54 PM GMT+08  • 2 min read
Medtecs signs letter of intent with Enimmune to market and promote Enimmune's 'Speedy Covid-19 Ag Rapid Test'
Medtecs says it will make further announcements in relation to the partnership.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Medtecs International, on Jan 14, signed a letter of intent (LOI) with Enimmune Corporation, where both companies seek to leverage on each other’s strengths to explore opportunities to market and promote Enimmune’s “Speedy Covid-19 Ag Rapid Test” in the Philippines.

Enimmune is a joint venture vaccine development and marketing company that is jointly established by Adimmune Corporation and other venture capital investors.

It began operations in the Philippines in 1989 and has since established a strong presence in the local market.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now